Joshua J. Freitas

MedicineSocial SciencesImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants”.

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Cell Reports(2022)10.1016/j.celrep.2022.110812

N/A

0.921DataRank · unranked

464 citations

Stefanie Žentelis, Lingshu Wang, Denisa Foster, Peter Vaillancourt, Matthew Wiggin +64 more

The effect of anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, on endogenous immune response to COVID-19 vaccination

medRxiv(2021)10.1101/2021.12.15.21267605

N/A

0.292DataRank · unranked

6 citations

Jay Tuttle, Lin Zhang, Josh Poorbaugh, Nicole L. Kallewaard, Peter Vaillancourt +11 more

The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination

UNC Libraries(2022)10.17615/77w4-hz26

N/A

0DataRank · unranked

1 citations

Nicole L. Kallewaard, Stephanie Beasley, Montanea Daniels, Joshua J. Freitas, Robert J. Benschop +11 more